DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Nephrocare Health Services Limited — Agreements

NSE 1 hr ago·14 Sept 2026, 1:04 pm

Nephrocare Health Services

Nephrocare Health Services Limited has announced the signing of new agreements, signaling an expansion of its operational footprint. This move is aimed at strengthening its network and enhancing service delivery capabilities across its key markets.

For investors, this development is significant as it indicates the company's proactive approach to growth and market penetration. Such agreements often lead to increased revenue streams and improved competitive positioning in the healthcare sector.

Investors should monitor the specific terms of these new deals and the timeline for their implementation. Keeping an eye on the company's future financial reports will be crucial to understanding the long-term impact of these strategic moves on its overall performance.